SP
Shreekant Panday
About Shreekant Panday
Data last updated:
Shreekant Panday is a Director at Bravo Pharmaceuticals Private Limited (since 2022). The companies operate in Pharma and Transport and Logistics. Bravo Pharmaceuticals Private Limited reported revenue of ₹6.47 Cr (FY 2024). Earlier, Shreekant Panday was a Director at Brasic Securities Private Limited (2024–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bravo Pharmaceuticals Private Limited U33110DL2011PTC220862 | Director | 02 Sep 2022 | 2011 | ₹6.47 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Brasic Securities Private Limited U66190DL1993PTC055426 | Director | 02 Nov 2024 | 1993 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shreekant Panday
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rakesh Pandey | 02259911 | Bravo Pharmaceuticals Private Limited | Director |
| Reena Singh | 05242708 | Bravo Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shreekant Panday
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shreekant Panday
Shreekant Panday currently holds 1 directorship: Bravo Pharmaceuticals Private Limited (Director, since 02 Sep 2022, revenue ₹6.47 Cr (FY 2024)).
Shreekant Panday was first appointed on 02 Sep 2022 as Director at Bravo Pharmaceuticals Private Limited. The most recent appointment on record is 02 Nov 2024 at Brasic Securities Private Limited.
Shreekant Panday held 1 earlier board appointment: Brasic Securities Private Limited (Director, 02 Nov 2024 to 13 Nov 2025).
The current boards of Shreekant Panday's companies include Rakesh Pandey (Bravo Pharmaceuticals Private Limited), Reena Singh (Bravo Pharmaceuticals Private Limited).